SARS-CoV-2 Variants: How COVID-19 Keeps Evolving
SARS-CoV-2 continually changes as it replicates. Most genetic changes do not transform the public-health picture, but some lineages can spread differently, evade existing immunity or alter how diagnostics, treatments or vaccines perform.
At a glance
Key points
- WHO system
- VOI · VUM · risk evaluation
- Major historical shift
- Alpha → Delta → Omicron
- Current VOI
- JN.1
- VUMs · 27 Jul 2026
- PQ.16.1.1 · NB.1.8.1 · XFG · BA.3.2
- Global sequencing
- Uneven and incomplete
- Why track
- Risk · immunity · vaccines · therapeutics
What makes a variant important
Every SARS-CoV-2 infection is an opportunity for the virus to accumulate genetic changes. Surveillance networks sequence a sample of infections and group related viruses into lineages. Public-health agencies then assess whether a lineage has characteristics that merit closer monitoring.
WHO updated its variant tracking system in March 2023 to reflect a landscape dominated by Omicron descendants. Labels such as variant of interest (VOI) and variant under monitoring (VUM) are surveillance categories, not a guarantee that a lineage will cause more severe disease.
Timeline
Major phases in variant evolution
This is a high-level reference timeline rather than a complete lineage tree.
- Late 2020
Alpha and other early variants changed the pandemic landscape
More transmissible lineages demonstrated that viral evolution could materially alter epidemic dynamics.
- 2021
Delta became globally dominant in many regions
Delta was associated with a major wave of severe disease before Omicron emerged.
- 26 Nov 2021
WHO designated Omicron a variant of concern
Omicron carried extensive spike changes and rapidly produced many descendant lineages.
- 18 Dec 2023
JN.1 designated a WHO variant of interest
JN.1 became an important ancestor for later circulating lineages.
- 27 Jul 2026
WHO updated its variants-under-monitoring list
PQ.16.1.1 joined NB.1.8.1, XFG and BA.3.2 in the current monitoring set.
Comparison
WHO variant tracking snapshot
Status changes over time. Always check the current WHO table before interpreting a lineage.
| WHO category | Lineages in the 27 Jul 2026 tracking table | Meaning |
|---|---|---|
| Variant of interest (VOI) | JN.1 (excluding descendants separately classified as VUMs) | A lineage with genetic changes and evidence that warrants ongoing international assessment. |
| Variants under monitoring (VUMs) | PQ.16.1.1; NB.1.8.1; XFG; BA.3.2 | Lineages with signals that justify enhanced monitoring while evidence is still developing. |
WHO dashboard data are limited by which countries sequence and submit specimens. A higher share among submitted sequences is not identical to population prevalence.
Evidence snapshot
How to interpret variant headlines
Variant names can travel faster than the evidence about their real-world effect.
Faster spread does not automatically mean more severe disease
Severity depends on viral properties, population immunity, age and risk profile, access to care and other factors.
Sequencing is not a census of every infection
Countries differ in how much they test, sequence and report; global percentages are estimates based on submitted samples.
Variant surveillance supports practical decisions
Tracking can inform vaccine composition, diagnostics, antiviral susceptibility and preparedness.
Sources
This page separates current clinical or public-health guidance from historical pandemic material. Recommendations can vary by country and may change as evidence evolves.
- 1. WHO. Tracking SARS-CoV-2 variants. Source ↗
- 2. WHO. COVID-19 dashboard — variant circulation. Source ↗
- 3. WHO. Classification of Omicron as a variant of concern. Source ↗
This article is based on trusted medical sources and is awaiting clinician review. It is not a substitute for personalized medical advice.